Meeting Coverage
SOHO
Society of Hematologic Oncology
Latest SOHO Meeting Coverage
Good response rate with camidanlumab tesirine, although a lot of patients experienced AEs
October 2, 2022
Belamaf plus lenalidomide-dexamethasone achieved encouraging responses
September 30, 2022
Strategy applied in OPTIC trial may mitigate adverse events without sacrificing benefit
September 29, 2022
About a third of patients, including those with TP53 mutations, achieved complete remission
September 29, 2022
Emphasis on novel biological approaches in treating patients with hematologic malignancies
September 26, 2022
Rational combinations, new targets, and a first-ever phase III trial with a survival endpoint
September 14, 2020
Also at SOHO: Ponatinib proves mettle in pretreated CML
September 13, 2016
Objective responses in a majority of patients
September 8, 2016
Latest Oncology/Hematology Meeting Coverage
-
AHNS: American Head & Neck Society
July 2023
-
ASCO Future Focus: Immunotherapy: Future Focus from the American Society of Clinical Oncology
June 2023
-
ASCO Video Pearls: Immunotherapy: Video Pearls from the American Society of Clinical Oncology
June 2023
-
ASCO Video Pearls: Renal Cell Carcinoma: Video Pearls from the American Society of Clinical Oncology
June 2023